8,61,000 Shares Allotted pursuant to conversion of warrants
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shelter Pharma Ltd has allotted 8,61,000 equity shares (face value ₹10 each) to 6 non-promoter investors who exercised their option to convert warrants. These warrants were originally issued on August 6, 2025 at ₹42.25 per warrant as part of a preferential allotment of 88,08,000 warrants, with only 25% paid upfront. The holders have now paid the remaining 75% (₹31.6875 per share), bringing in ₹2.72 crore to the company. As a result, the company's paid-up equity capital has increased from ₹14.00 crore (1.40 crore shares) to ₹14.86 crore (1.48 crore shares), a dilution of roughly 6.1%.
This is a routine follow-through from the earlier warrant issuance. ₹2.72 crore of fresh equity capital comes into the company at ₹42.25 per share, which is above face value. The conversion was at a premium, so existing shareholders are not directly diluted in terms of value, though total share count rises. No immediate negative signal, but it confirms earlier capital-raising activity is moving forward.